RIL
CYTK icon

Rothschild Investment LLC’s Cytokinetics CYTK Stock Holding History

Rothschild Investment LLC’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.5K Buy
205
+18
+10% +$1.14K ﹤0.01% 1569
2025
Q4 		$11.9K Buy
187
+2
+1% +$124 ﹤0.01% 1509
2025
Q3 		$10.2K Sell
185
-35
-16% -$1.44K ﹤0.01% 1441
2025
Q2 		$7.27K Buy
220
+60
+38% +$2.09K ﹤0.01% 1342
2025
Q1 		$6.43K Buy
160
+55
+52% +$2.53K ﹤0.01% 1326
2024
Q4 		$4.94K Buy
105
+10
+11% +$519 ﹤0.01% 1347
2024
Q3 		$5.02K Buy
95
+80
+533% +$4.46K ﹤0.01% 1291
2024
Q2 		$813 Buy
15
+5
+50% +$302 ﹤0.01% 1769
2024
Q1 		$701 Buy
+10
New +$773 ﹤0.01% 1295

Other funds holding CYTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return